trans-Activation of the HIV type 1 promoter by 7,8-dihydroneopterin in vitro.

Research paper by G G Baier-Bitterlich, D D Fuchs, R R Zangerle, P A PA Baeuerle, E R ER Werner, F F Fresser, F F Uberall, G G Baier, H H Wachter

Indexed on: 20 Jan '97Published on: 20 Jan '97Published in: AIDS research and human retroviruses


Infection with human immunodeficiency virus type 1 and 2 is associated with elevated concentrations of neopterin, released in large quantities by human macrophages on stimulation with interferon gamma. Evidence has suggested a potential role of neopterin derivatives in oxygen radical-mediated processes. Here we show that the redox-sensitive transcription factors AP-1 and NF-kappaB are activated by 7,8-dihydroneopterin, either directly (AP-1), or by the synergistic action with tumor necrosis factor alpha (NF-kappaB). We could further demonstrate that 7,8-dihydroneopterin enhances HIV-1 expression as shown in transient transfection assays using HIV-1 CAT promoter-reporter gene constructs. In sera of HIV+ patients 7,8-dihydroneopterin significantly correlated with neopterin and HIV-1 p24 antigen. On the basis of our data we therefore assume that 7,8-dihydroneopterin might augment progression to higher stages of HIV-associated disease.